Top

Published in:

01-11-2014

Safe Negative Margin Width in Breast Conservative Therapy: Results from a Population with a High Percentage of Negative Prognostic Factors

Authors: Abu Bakar Bhatti, Amina Khan, Narjis Muzaffar, Neelam Siddiqui, Aamir Syed, Mazhar Shah, Awais Aamir, Arif Jamshed

Published in: World Journal of Surgery | Issue 11/2014

Abstract

Background

There remains a controversy in the literature regarding adequate width of negative surgical margins in breast conservative therapy (BCT). It is now advocated that no tumor on an inked margin is a safe negative margin. Majority of studies on the outcomes of BCT had patients with favorable prognostic factors. Pakistani population has a high expression of unfavorable prognostic factors. The objective of this study was to determine a safe negative margin width in Pakistani population that undergoes BCT.

Methods

A total of 603 patients with identifiable surgical margins underwent BCT from 1997 to 2009 in Shaukat Khanum Cancer Hospital. Patients were divided into close (≤2 mm), free (>2–10 mm), and wide (>10 mm) margin groups. Locoregional recurrence was defined as recurrence within the operated breast, ipsilateral axilla, or supraclavicular or internal mammary lymph nodes. Locoregional recurrence-free survival was calculated from the date of surgery to the date of locoregional recurrence. Five-year locoregional recurrence-free survival was determined for margin groups. Univariate and multivariate Cox proportional hazard analyses were performed to determine independent predictors of locoregional recurrence.

Results

A total of 415 (69 %) patients were <50 years of age. There were 82 (15 %) T3/T4, 337 (56 %) poorly differentiated, and 238 (39 %) ER/PR −ve tumors. Nodal positivity was present in 314 (52 %) patients. The actual number of locoregional recurrences was 16 (12 %), 8 (3 %), and 10 (4.6 %), respectively (P = 0.002). Expected 5-year locoregional recurrence-free survival was 90, 97, and 96 %, respectively (P = 0.002). On multivariate analysis, tumor size, nodal involvement, and negative margin width were independent predictors of locoregional recurrence.

Conclusion

A negative margin width of 2 mm might represent an adequate negative margin width in the Pakistani population undergoing breast conservative therapy.

Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241PubMedCrossRef

Van Dongen JA, Voogd AC, Fentiman IS et al (2000) Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 92:1143–1150PubMedCrossRef

Kreike B, Hart AA, van de Velde T et al (2008) Continuing risk of ipsilateral breast relapse after breast-conserving therapy at long-term follow-up. Int J Radiat Oncol Biol Phys 71:1014–1021PubMedCrossRef

Komoike Y, Akiyama F, Iino Y et al (2006) Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases. Cancer 106:35–41PubMedCrossRef

Nottage MK, Kopciuk KA, Tzontcheva A et al (2006) Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on disease-specific survival of women with node-negative breast cancer: a prospective cohort study. Breast Cancer Res 8:R44PubMedCrossRefPubMedCentral

Bijker N, Peterse JL, Duchateau L et al (2001) Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 19:2263–2271PubMed

Jobsen JJ, Van Der Palen J, Ong F et al (2007) Differences in outcome for positive margins in a large cohort of breast cancer patients treated with breast-conserving therapy. Acta Oncol 46:172–180PubMedCrossRef

Arriagada R, Lê MG, Guinebretière JM et al (2003) Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. Ann Oncol 14:1617–1622PubMedCrossRef

Poggi MM, Danforth DN, Sciuto LC et al (2003) Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 98:697–702PubMedCrossRef

10.

Groot G, Rees H, Pahwa P et al (2011) Predicting local recurrence following breast-conserving therapy for early stage breast cancer: the significance of a narrow (≤2 mm) surgical resection margin. J Surg Oncol 103:212–216PubMedCrossRef

11.

Hewes JC, Imkampe A, Haji A et al (2009) Importance of routine cavity sampling in breast conservation surgery. Br J Surg 96:47–53PubMedCrossRef

12.

Park CC, Mitsumori M, Nixon A et al (2000) Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 18:1668–1675PubMed

13.

Taghian A, Mohiuddin M, Jagsi R et al (2005) Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg 241:629–639PubMedCrossRefPubMedCentral

14.

Morrow M, Harris JR, Schnitt SJ (2012) Surgical margins in lumpectomy for breast cancer—bigger are not better. N Engl J Med 367:79–82PubMedCrossRef

15.

Ahmed R, Shaikh H, Hasan SH (1997) Is breast carcinoma a different disease in Pakistani population? J Pak Med Assoc 47:114–116PubMed

16.

Revesz E, Khan SA (2011) What are safe margins of resection for invasive and in situ breast cancer? Oncology (Williston Park) 25:890–895

17.

Cefaro GA, Genovesi D, Marchese R et al (2006) Predictors of local recurrence after conservative surgery and whole-breast irradiation. Breast Cancer Res Treat 98:329–335PubMedCrossRef

18.

Houssami N, Macaskill P, Marinovich ML et al (2010) Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy. Eur J Cancer 46:3219–3232PubMedCrossRef

19.

King TA, Sakr R, Patil S et al (2011) Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol 29:2158–2164PubMedCrossRef

20.

Noh WC, Paik NS, Kim MS et al (2005) Ipsilateral breast tumor recurrence after breast-conserving therapy: a comparison of quadrantectomy versus lumpectomy at a single institution. World J Surg 29:1001–1006. doi:10.1007/s00268-005-7928-4 PubMedCrossRef

21.

Miller AR, Brandao G, Prihoda TJ et al (2004) Positive margins following surgical resection of breast carcinoma: analysis of pathologic correlates. J Surg Oncol 86:134–140PubMedCrossRef

22.

Yildirim E (2009) Locoregional recurrence in breast carcinoma patients. Eur J Surg Oncol 35:258–263PubMedCrossRef

23.

Kurniawan ED, Wong MH, Windle I et al (2008) Predictors of surgical margin status in breast-conserving surgery within a breast screening program. Ann Surg Oncol 15:2542–2549PubMedCrossRef

24.

Romond EH, Perez EA, Bryant J et al (2005) Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 353:1673–1684PubMedCrossRef

25.

Kyndi M, Sørensen FB, Knudsen H et al (2008) Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer. J Clin Oncol 26:1419–1426PubMedCrossRef

26.

Millar EKA, Graham PH, O’Toole SA et al (2009) Prediction of local recurrence, distant metastases, and death after breast conserving therapy in early-stage invasive breast cancer using a five-biomarker panel. J Clin Oncol 27:4701–4708PubMedCrossRef

27.

Nguyen PL, Taghian AG, Katz MS et al (2008) Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 26:2373–2378PubMedCrossRef

28.

Kunos C, Latson L, Overmoyer B et al (2006) Breast conservation surgery achieving > or =2 mm tumor-free margins results in decreased local-regional recurrence rates. Breast J 12:28–36PubMedCrossRef

29.

Lupe K, Truong PT, Alexander C et al (2011) Subsets of women with close or positive margins after breast-conserving surgery with high local recurrence risk despite breast plus boost radiotherapy. Int J Radiat Oncol Biol Phys 81:e561–e568PubMedCrossRef

30.

Akbari ME, Akbari M, Zirakzadeh H et al (2011) Margin status influence on the outcome of patients treated with breast conserving surgery. Iran J Cancer Prev 4:177–182

31.

Pleijhuis RG, Graafland M, de Vries J et al (2009) Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions. Ann Surg Oncol 16:2717–2730PubMedCrossRefPubMedCentral

Title: Safe Negative Margin Width in Breast Conservative Therapy: Results from a Population with a High Percentage of Negative Prognostic Factors
Authors: Abu Bakar Bhatti
Amina Khan
Narjis Muzaffar
Neelam Siddiqui
Aamir Syed
Mazhar Shah
Awais Aamir
Arif Jamshed
Publication date: 01-11-2014
Publisher: Springer US
Published in: World Journal of Surgery / Issue 11/2014
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-014-2651-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Safe Negative Margin Width in Breast Conservative Therapy: Results from a Population with a High Percentage of Negative Prognostic Factors

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 11/2014

Chylothorax Complicating Video-Assisted Thoracoscopic Surgery for Non-small Cell Lung Cancer

Changing Trends in Thyroid and Parathyroid Surgery over the Decade: Is Same-day Discharge Feasible in the United Kingdom?

Biliary Complications After Pancreaticoduodenectomy: Skinny Bile Ducts Are Surgeons’ Enemies

A Novel Method for Laparoscopic Splenectomy in the Setting of Hypersplenism Secondary to Liver Cirrhosis: Ten Years’ Experience

Laparoscopic Spleen-Preserving Distal Pancreatectomy: Comparative Study of Spleen Preservation with Splenic Vessel Resection and Splenic Vessel Preservation

Pancreatic Secondary Lesions from Renal Cell Carcinoma